Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to Ketamine.
- Published in:
- Frontiers in Neuroscience, 2021, v. 15, p. 1, doi. 10.3389/fnins.2021.698633
- By:
- Publication type:
- Article
Works by Tiger, Mikael
Results: 14
1
2
Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2022, v. 42, n. 4, p. 630, doi. 10.1177/0271678X211049185
- By:
- Publication type:
- Article
3
A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression.
- Published in:
- Translational Psychiatry, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41398-020-0844-4
- By:
- Publication type:
- Article
4
[<sup>18</sup>F]FE‐PE2I PET is a diagnostic tool in dementia with Lewy bodies.
- Published in:
- Psychiatry & Clinical Neurosciences Reports, 2025, v. 4, n. 2, p. 1, doi. 10.1002/pcn5.70123
- By:
- Publication type:
- Article
5
The 5-HT<sub>1B</sub> receptor - a potential target for antidepressant treatment.
- Published in:
- Psychopharmacology, 2018, v. 235, n. 5, p. 1317, doi. 10.1007/s00213-018-4872-1
- By:
- Publication type:
- Article
6
No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [<sup>11</sup>C]AZ10419369 binding measured with PET in healthy volunteers.
- Published in:
- Synapse, 2014, v. 68, n. 10, p. 480, doi. 10.1002/syn.21761
- By:
- Publication type:
- Article
7
Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [<sup>11</sup>C]AZ10419369 Positron Emission Tomography Study.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 4, p. 241, doi. 10.1093/ijnp/pyac084
- By:
- Publication type:
- Article
8
Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.
- Published in:
- International Journal of Neuropsychopharmacology, 2012, v. 15, n. 8, p. 1167, doi. 10.1017/S1461145711001945
- By:
- Publication type:
- Article
9
Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study.
- Published in:
- BJPsych Open, 2023, v. 9, n. 2, p. 1, doi. 10.1192/bjo.2023.5
- By:
- Publication type:
- Article
10
The effect of anaesthetic dose on response and remission in electroconvulsive therapy for major depressive disorder: nationwide register-based cohort study.
- Published in:
- BJPsych Open, 2021, v. 7, n. 2, p. 1, doi. 10.1192/bjo.2021.31
- By:
- Publication type:
- Article
11
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic.
- Published in:
- Translational Psychiatry, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41398-024-02894-z
- By:
- Publication type:
- Article
12
Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study.
- Published in:
- International Journal of Psychiatry in Clinical Practice, 2022, v. 26, n. 3, p. 251, doi. 10.1080/13651501.2021.2003405
- By:
- Publication type:
- Article
13
Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression.
- Published in:
- Psychiatry & Clinical Neurosciences, 2020, v. 74, n. 8, p. 424, doi. 10.1111/pcn.13020
- By:
- Publication type:
- Article
14
[<sup>11</sup>C]raclopride positron emission tomography study of dopamine‐D<sub>2/3</sub> receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects.
- Published in:
- Psychiatry & Clinical Neurosciences, 2020, v. 74, n. 4, p. 263, doi. 10.1111/pcn.12980
- By:
- Publication type:
- Article